NasdaqCM - Nasdaq Real Time Price USD

Jaguar Health, Inc. (JAGX)

0.1800 +0.0100 (+5.88%)
At close: April 26 at 4:00 PM EDT
0.1822 +0.00 (+1.22%)
After hours: April 26 at 7:59 PM EDT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for JAGX

Recent News: JAGX

View More
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in Support of Company’s Expanding Focus on Cancer Supportive Care

Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in Support of Company’s Expanding Focus on Cancer Supportive Care
ACCESSWIRE 4 days ago
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care

Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care
ACCESSWIRE 8 days ago
Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care

Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care
ACCESSWIRE 10 days ago
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders

Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
ACCESSWIRE 17 days ago
Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement

Jaguar Health Granted Extension Until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement
ACCESSWIRE 18 days ago
Jaguar Health Full Year 2023 Earnings: US$1.79 loss per share (vs US$36.18 loss in FY 2022)

Jaguar Health Full Year 2023 Earnings: US$1.79 loss per share (vs US$36.18 loss in FY 2022)
Simply Wall St. 23 days ago
Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call Transcript

Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2023 Earnings Call Transcript
Insider Monkey 24 days ago
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International

Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
ACCESSWIRE 24 days ago

Q4 2023 Jaguar Health Inc Earnings Call
Thomson Reuters StreetEvents 24 days ago
Jaguar Health Reports 2023 Financial Results

Jaguar Health Reports 2023 Financial Results
ACCESSWIRE 25 days ago
Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials & Corporate Updates

Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials & Corporate Updates
ACCESSWIRE 30 days ago
GEN to Commercialize Jaguar Health's Crofelemer in Turkey and Eight Neighboring Countries and Invest $2 Million in Jaguar Stock at 75% Premium to Market

GEN to Commercialize Jaguar Health's Crofelemer in Turkey and Eight Neighboring Countries and Invest $2 Million in Jaguar Stock at 75% Premium to Market
ACCESSWIRE last month
View More

Related Tickers

NKGN NKGen Biotech, Inc.
1.6100
-18.69%
 
MLEC Moolec Science SA
1.4500
+2.11%
 
PCSA Processa Pharmaceuticals, Inc.
2.1500
-11.52%
 
PALI Palisade Bio, Inc.
6.05
-2.89%
 
ABVC ABVC BioPharma, Inc.
1.4200
-10.69%
 
BPTH Bio-Path Holdings, Inc.
2.6800
+1.71%
 
KTRA Kintara Therapeutics, Inc.
0.1488
-5.82%
 
CDTX Cidara Therapeutics, Inc.
12.63
-2.85%
 
OCGN Ocugen, Inc.
1.2800
+8.47%
 
EYEN Eyenovia, Inc.
0.6282
-11.68%